Trial Profile
Clinical Trials Insight: 700011330
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 17 Jan 2006
Price :
$35
*
At a glance
- Drugs ENMD 0995 (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Pharmacokinetics
- 17 Jan 2006 New trial record.